[Ip-health] News: US Pharmacist- Access to Medicine Index Ranks Generic Manufacturers

Terri - Louise Beswick Terri at haiweb.org
Mon Aug 16 01:30:43 PDT 2010

Access to Medicine Index Ranks Generic Manufacturers


By Staff




US Pharm 2010;35(8):58


For the first time, the Access to Medicine Index has given generic drug
makers a separate ranking on its biannual index, and Ranbaxy
Laboratories Ltd. and Cipla, both based in India, top the list. "The
Access to Medicine Index independently assesses how individual
pharmaceutical companies perform in promoting universal access to
essential medicines, and is thus an important tool in improving
performance," said Carissa Etienne, MD, assistant director-general at
the World Health Organization. Manufacturers were rated on seven
factors, including access to medicine management, public policy and
market influence, and product donations and philanthropy. The index was
first published in 2008 by the Netherlands-based nonprofit Access to
Medicine Foundation. Other generic manufacturers included in the 2010
index are Dr. Reddy's Laboratories Ltd., Mylan Inc., Sun Pharmaceuticals
Ltd., and Teva Pharmaceutical Industries Ltd.



More information about the Ip-health mailing list